Efficacy and Safety of Sacituzumab Govitecan for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).

Tolentino LG, Khaustova M, Alrwaitey RZ, Chintala AS, Baidya D, Kumar VY, Abdelrahim D, Ejiogu NSS, Bhardwaj V, Peethambar BA, Ayyan M

Open source

DOI: 10.1097/coc.0000000000001365
Published: 2026 Sep 9
Container: American journal of clinical oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/coc.0000000000001365,
  title = {Efficacy and Safety of Sacituzumab Govitecan for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).},
  author = {Tolentino LG and Khaustova M and Alrwaitey RZ and Chintala AS and Baidya D and Kumar VY and Abdelrahim D and Ejiogu NSS and Bhardwaj V and Peethambar BA and Ayyan M},
  year = {2026},
  journal = {American journal of clinical oncology},
  doi = {10.1097/coc.0000000000001365},
  url = {https://doi.org/10.1097/coc.0000000000001365}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Sacituzumab Govitecan for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).
AU  - Tolentino LG
AU  - Khaustova M
AU  - Alrwaitey RZ
AU  - Chintala AS
AU  - Baidya D
AU  - Kumar VY
AU  - Abdelrahim D
AU  - Ejiogu NSS
AU  - Bhardwaj V
AU  - Peethambar BA
AU  - Ayyan M
PY  - 2026
JO  - American journal of clinical oncology
DO  - 10.1097/coc.0000000000001365
UR  - https://doi.org/10.1097/coc.0000000000001365
ER  -

APA

LG, T., M, K., RZ, A., AS, C., D, B., VY, K., D, A., NSS, E., V, B., BA, P., & M, A. (2026). Efficacy and Safety of Sacituzumab Govitecan for Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).. American journal of clinical oncology. https://doi.org/10.1097/coc.0000000000001365

Source records

pubmed · retrieved 2026-09-26T04:27:34.986Z